Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Authors
Keywords
Coronavirus disease 2019, Covid-19, Diabetes, GLP-1RA, Anti-diabetic
Journal
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 179, Issue -, Pages 109031
Publisher
Elsevier BV
Online
2021-08-29
DOI
10.1016/j.diabres.2021.109031
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
- (2021) Chioma Izzi-Engbeaya et al. BMJ Open Diabetes Research & Care
- Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
- (2021) Simone Bastrup Israelsen et al. DIABETES OBESITY & METABOLISM
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2021) Timotius Ivan Hariyanto et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Parkinson’s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Cynthia Putri et al. PARKINSONISM & RELATED DISORDERS
- Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
- (2021) Timotius I. Hariyanto et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis
- (2021) Timotius Ivan Hariyanto et al. SLEEP MEDICINE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
- (2020) Maria Mirabelli et al. International Journal of Environmental Research and Public Health
- Letter to the Editor: Comment on GLP-1-based drugs and COVID-19 treatment
- (2020) Tianru Jin et al. Acta Pharmaceutica Sinica B
- Diabetes increases the mortality of patients with COVID-19: a meta-analysis
- (2020) Zeng-hong Wu et al. ACTA DIABETOLOGICA
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
- (2020) Vincenzo M. Monda et al. Diabetes Therapy
- Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily
- (2020) Silverii Giovanni Antonio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Diabetes, infection risk and COVID-19
- (2020) Suheda Erener Molecular Metabolism
- COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
- (2020) Harald Sourij et al. DIABETES OBESITY & METABOLISM
- Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection
- (2020) Timotius Ivan Hariyanto et al. JOURNAL OF MEDICAL VIROLOGY
- Obesity in patients with COVID-19: a systematic review and meta-analysis
- (2020) Yi Huang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients
- (2019) Paola Rogliani et al. RESPIRATORY MEDICINE
- A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
- (2018) Vanita R. Aroda DIABETES OBESITY & METABOLISM
- Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
- (2018) Shinji Toki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
- (2018) Li Zhao et al. Frontiers in Endocrinology
- Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice
- (2016) Feng Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
- (2016) A Blackman et al. INTERNATIONAL JOURNAL OF OBESITY
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice
- (2015) Tao Zhu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
- Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice
- (2013) Niels-Erik Viby et al. ENDOCRINOLOGY
- GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats
- (2010) Hui-Chun Ku et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started